Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Non Operating Income: 2012-2025

Historic Non Operating Income for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to $1.2 million.

  • CorMedix's Non Operating Income rose 140.97% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4.43%. This contributed to the annual value of $3.0 million for FY2024, which is 15.77% up from last year.
  • Latest data reveals that CorMedix reported Non Operating Income of $1.2 million as of Q3 2025, which was up 52.63% from $805,983 recorded in Q2 2025.
  • CorMedix's 5-year Non Operating Income high stood at $1.2 million for Q3 2025, and its period low was -$11,066 during Q4 2021.
  • Its 3-year average for Non Operating Income is $729,026, with a median of $626,946 in 2023.
  • As far as peak fluctuations go, CorMedix's Non Operating Income tumbled by 379.88% in 2021, and later soared by 24,647.35% in 2023.
  • CorMedix's Non Operating Income (Quarterly) stood at -$11,066 in 2021, then soared by 1,729.11% to $180,277 in 2022, then soared by 568.06% to $722,929 in 2023, then fell by 29.38% to $528,396 in 2024, then spiked by 140.97% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $805,983 for Q2 2025, and $518,618 during Q1 2025.